This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Takashi Okazaki: Innovator in Antitumor Research
Introduction
Takashi Okazaki is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of substances with potential antitumor properties. His work is recognized for its innovative approach to addressing cancer treatment.
Latest Patents
Okazaki holds a patent for a proteinaceous substance that exhibits antitumorous action. This invention is characterized by specific biochemical properties that may play a crucial role in cancer therapy. The patent is titled "Proteinaceous substance showing antitumorous action and its preparing," highlighting its potential applications in medical science.
Career Highlights
Throughout his career, Takashi Okazaki has been associated with Kyorin Pharmaceutical Co., Ltd., where he has contributed to various research initiatives. His work has focused on the intersection of biochemistry and pharmacology, aiming to develop effective treatments for cancer.
Collaborations
Okazaki has collaborated with esteemed colleagues such as Tsutomu Irikura and Koichi Takagi. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
In summary, Takashi Okazaki is a prominent inventor whose work in antitumor research has the potential to impact cancer treatment significantly. His contributions to the field are marked by his innovative patent and collaborative efforts with fellow researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile